MetLife Investment Management
TWST icon

MetLife Investment Management’s Twist Bioscience TWST Stock Holding History

MetLife Investment Management’s Portfolio TWST Stock Details TWST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.72M Buy
36,123
+3,192
+10% +$208K 0.02% 803
2026
Q1 		$1.56M Sell
32,931
-305
-0.9% -$13.7K 0.01% 1189
2025
Q4 		$1.05M Sell
33,236
-1,491
-4% -$46.5K 0.01% 1396
2025
Q3 		$977K Hold
34,727
– – ﹤0.01% 1464
2025
Q2 		$1.28M Hold
34,727
– – 0.01% 1186
2025
Q1 		$1.36M Sell
34,727
-495
-1% -$22.3K 0.01% 1223
2024
Q4 		$1.64M Buy
35,222
+1,987
+6% +$89.8K 0.01% 1156
2024
Q3 		$1.5M Hold
33,235
– – 0.01% 1172
2024
Q2 		$1.64M Buy
33,235
+3,189
+11% +$130K 0.01% 1072
2024
Q1 		$1.03M Buy
30,046
+356
+1% +$12.8K 0.01% 1282
2023
Q4 		$1.09M Hold
29,690
– – 0.01% 1245
2023
Q3 		$602K Hold
29,690
– – ﹤0.01% 1514
2023
Q2 		$607K Hold
29,690
– – ﹤0.01% 1569
2023
Q1 		$448K Hold
29,690
– – ﹤0.01% 1708
2022
Q4 		$707K Hold
29,690
– – 0.01% 1412
2022
Q3 		$1.05M Hold
29,690
– – 0.01% 1165
2022
Q2 		$1.04M Hold
29,690
– – 0.01% 1188
2022
Q1 		$1.47M Buy
29,690
+13,308
+81% +$738K 0.01% 1127
2021
Q4 		$1.27M Hold
16,382
– – 0.01% 1032
2021
Q3 		$1.75M Sell
16,382
-1,060
-6% -$121K 0.02% 919
2021
Q2 		$2.32M Hold
17,442
– – 0.02% 817
2021
Q1 		$2.16M Buy
17,442
+3,997
+30% +$607K 0.02% 836
2020
Q4 		$1.9M Hold
13,445
– – 0.02% 854
2020
Q3 		$1.02M Hold
13,445
– – 0.01% 1015
2020
Q2 		$609K Buy
13,445
+1,813
+16% +$65.1K 0.01% 1274
2020
Q1 		$356K Buy
11,632
+1,390
+14% +$37.4K ﹤0.01% 1395
2019
Q4 		$215K Hold
10,242
– – ﹤0.01% 1939
2019
Q3 		$245K Hold
10,242
– – ﹤0.01% 1829
2019
Q2 		$297K Buy
+10,242
New +$271K ﹤0.01% 1793

Other funds holding TWST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
ARK Investment Management
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
EdgePoint Investment Group
EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

MetLife Investment Management's TWST Position: Q2 2026 in Review

MetLife Investment Management increased its Twist Bioscience (TWST) stake by 9.7% in Q2 2026, buying an estimated $208K and bringing the position to 36,123 shares worth $3.72M. The position accounts for 0.02% of the portfolio, ranked #803.

MetLife Investment Management first reported a position in TWST in Q2 2019 and has held it in 29 quarters since. 337 funds tracked by Wall St. Rank hold TWST as of Q2 2026.

  • MetLife Investment Management held 36,123 shares of Twist Bioscience worth $3.72M as of Q2 2026.
  • MetLife Investment Management bought 3,192 Twist Bioscience shares in Q2 2026, an estimated $208K.
  • Twist Bioscience made up 0.02% of MetLife Investment Management's portfolio in Q2 2026, its #803 holding.
  • MetLife Investment Management first reported a position in Twist Bioscience in Q2 2019 and has held it in 29 quarters since.
  • 337 funds tracked by Wall St. Rank held Twist Bioscience as of Q2 2026.

Based on MetLife Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.